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Introduction
Imaging techniques used in experimental or medical fields are 
currently undergoing spectacular development. Whether based 
on the use of ultrasound (Doppler imaging), x-rays (compu-
terized tomography, CT scan), or magnetic resonance imaging 
(MRI), they offer an unprecedented tool for anatomical or 
physiological explorations. In this review, we highlight the possi-
bilities offered by MRI and its applications to large animal models 
in the context of preclinical research. MRI is a nonionizing 
imaging method that combines both radio-frequency electro-
magnetic pulses and a strong magnetic field. First, we describe 
the principles and potency of magnetic brain imaging to provide 
a baseline understanding of the principles underlying this tech-
nology as well as an appreciation of the benefits and limitations 
of its use. We also describe how these techniques are currently 
being applied to large animal models, especially for neurobio-
logical research in sheep. Given that MRI approaches are still 
in their infancy with respect to animal models, the development 
of associated tools will certainly boost the application of MRI 
to large animal models. Finally, we illustrate the possibilities of 
the use of MRI in the case of a pediatric neurodegenerative dis-
ease (Batten disease) on sheep genetic models of proven validity, 
to explore the pathophysiological mechanisms involved, and the 
development of therapeutic strategies.
Magnetic Resonance Imaging Principles
MRI is based on the absorption and emission of radio-
frequency energy from specific atomic nuclei placed in a strong 
magnetic field. Hydrogens atoms (protons) are the most fre-
quently used because they are highly abundant in water, fat, 
proteins, carbohydrates, and nucleic acids in tissues of living 
organisms. Protons (hydrogen nuclei) exhibit an intrinsic prop-
erty of “spin” in which they rotate around their axes and being 
charged particles, this spin produces a small magnetic field. 
When outside of an external magnetic field, spins (protons) will 
point randomly in any direction, thus yielding a null magnetiza-
tion moment. Placed in a strong magnetic field, B0, protons ex-
hibit a weak tendency to align with the direction of B0 (Figure 
1A). In addition, protons turn around B0 like gyroscopes (pre-
cession); thus, the axis of rotation traces out a circular path 
around the direction of the magnetic field at the Larmor fre-
quency (ω0 = γB0). Together, the many spinning protons form a 
net magnetization, M, parallel to B0. An application of a radio-
frequency (RF) pulse (Figure 1B), B1, perpendicular to B0, with 
a frequency equal to ω0, pushes M away from B0 (resonance, 
Implications
•  Magnetic resonance imaging is a very powerful ap-
proach to perform anatomical and functional imaging 
explorations.
•  Large animal models are perfectly suited for MRI 
studies using clinical devices and these tools are cur-
rently being developed and improved.
•  Here we highlight an example of MRI to demonstrate 
the efficacy of gene therapy in sheep models of Batten 
disease, a pediatric neurodegenerative disease.
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Figure 1C). Once the RF signal stops, M returns to equilibrium 
(relaxation) such that it is parallel again to B0. The net magnet-
ization also processes around B0, and as it relaxes to equilib-
rium, it induces a signal (free-induction decay [FID]) which can 
be measured by a coil placed around the object being imaged 
and reconstructed to obtain three-dimensional (3D) gray-scale 
MR images (Figure 1D). Localization of the signal in the 3D 
space is ensured by magnetic field gradients. Finally, the ac-
quisition parameters have to be chosen to correspond to the 
constraints of the spatial resolution (voxel size) and the desired 
signal quality (signal-to-noise ratio).
By nature, MRI is a highly multimodal imaging approach. 
First, MRI can be used to provide anatomical images (Figure 
2A), which can express various contrasts depending on the 
parameters of the excitation used. This contrast is due to the 
various relaxation properties of the protons in the tissues. 
Among the major image contrasts are T1- and T2-weighted im-
ages, which reflect two different relaxation times (T1 longitudinal 
relaxation time vs. T2 transverse relaxation time). T1- and T2-
weighted images can be easily differentiated by the appearance 
of fluids, which appear black on T1 in contrast to white on T2. 
Many other sequences are available to create various contrasts 
that can bring complimentary information to the anatomical 
question being explored. Furthermore, many contrast agents 
can be used to enhance the visualization of specific structures. 
For example, gadolinium is used routinely in tumor imaging to 
shorten T1 relaxation times, thereby enhancing image contrast.
Another important imaging technique relies on functional 
MRI approaches. Functional MRI (fMRI) is an indirect measure 
of brain activity which detects functional change associated with 
blood flow oxygenation. Indeed, the deoxyhemoglobin acts as 
an endogenous contrast agent which reduces the signal in T2-
weighted images when its concentration increases. This modality 
relies on the fact that in the brain, neuronal activations are tightly 
coupled with cerebral hemodynamic responses and permit func-
tional exploration of the brain during a task or at rest. In humans 
or in rodents, the main form of fMRI uses the blood-oxygen-level 
dependent (BOLD) contrast expressed in response to various 
stimulations such as a sensory stimulation or performance of a 
motor/cognitive task. In addition, “resting state” fMRI has be-
come ubiquitous in recent years. This measures BOLD fluctuations 
in the absence of an overt task and investigates how spatially dis-
tinct regions of the brain are functionally connected. Application 
of this technique has identified many functional brain networks; 
the most well-described is the default mode network (DMN), a 
large-scale brain network of interacting structures which express a 
highly correlated neuronal activity (Figure 2B).
Diffusion-weighted MRI is another important type of MRI 
that allows the mapping of in vivo diffusion of water molecules 
in biological tissues, which reflects the interactions of water 
molecules with tissue components, such as macromolecules, 
fibers, and cell membranes. This technique can therefore re-
veal anatomical details about tissue architecture. In the field of 
neuroimaging, a special type of diffusion-weighted MRI called 
diffusion tensor imaging (DTI) is widely used to map the main 
white matter tracts of the brain (Figure 2C).
Finally, there is nuclear magnetic resonance (NMR) spec-
troscopy, sometimes shortened to MR spectroscopy, which is 
based on small changes in the intramolecular magnetic field 
around an atom because of the different influences of dif-
ferent adjacent atoms and thus small shifts in the resonance 
frequency, giving access to details of the bonding structure 
of specific molecules. This is usually used for the analysis and 
identification of monomolecular organic compounds, such as 
for the analysis of metabolic changes in a tissue. For example, 
MR spectroscopy is used clinically to grade tumor malignancy 
on the basis of their metabolic activity.
Use of MRI on Large Animal Models for 
Preclinical Research
Large “domestic” animal models (sheep, goats, pigs, etc.) are 
of interest for a range of fundamental, agricultural, and preclin-
ical research purposes. Often they exhibit interesting features for 
Figure 1. Schematic representation of magnetic resonance imaging principles. (A) When placed in a strong magnetic field B0, protons align themselves parallel 
or antiparallel with the direction of B0. (B) The application of a RF pulse B1 perpendicular to B0 and at the same frequency of  B0 allows the longitudinal mag-
netization to tilt away from B0 (resonance). (C) Once the RF signal stops, M returns to equilibrium (relaxation) such that it aligns again with B0. (D) During re-
laxation, protons lose energy by emitting a RF signal Free Induction Decay (FID) which can be measured by a coil placed around the object being imaged and 
subsequently reconstructed to obtain 3D gray-scale MR images.
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preclinical research because their anatomy and physiology may be 
closer to humans than rodents. For example, the gross anatomy of 
pig or sheep brains is quite similar to that of primates, including 
humans. Brains from domestic animals show a high degree of cor-
tical gyrification, in contrast to rodents which have a lissencephalic 
cortex. Pigs are monogastric and have a digestive system that is 
very close to humans both anatomically and physiologically. In 
this regard, such models could become an alternative to primates 
for specific fields, especially given the financial difficulties and eth-
ical considerations associated with primate models.
Due to their evolutionary history, domestic animals also ex-
hibit specific physiological regulations that can be complimentary 
to those observed in rodents. For example, small ruminants are 
seasonal breeders, a characteristic not found in many laboratory 
animals, which has important consequences for animal production 
(Malpaux et al., 2001). Sheep are also a valuable model to study 
the effects of early brain development and sexual differentiation on 
later adult life (Roselli and Stormshak, 2010). Finally, sheep give 
birth to precocial young which are fully developed at birth in con-
trast to rodents where young are highly immature. Such features 
allow the study of mother-young attachment processes, which are 
based on individual recognition processes (Nowak et al., 2011).
A relatively long lifespan is an additional characteristic 
of interest for experimental research on large animal models. 
Although this could be a drawback when considering the costs 
associated with their breeding and maintenance, it is clearly an 
advantage when one wants to explore fine developmental pro-
cesses or the long-term development of pathological events and 
the effects of potential experimental/curative treatments. In add-
ition, the fact that large animals are domesticated also implies 
that they have been selected for their social abilities and are ac-
customed to the presence of humans. Therefore, manipulation of 
domestic animals  is relatively easy with limited stressful conse-
quences. If necessary, habituation procedures can be performed 
routinely. Finally, due to their size, it is clear that specific sam-
pling which necessitates a minimal amount of material can be 
performed much more easily on large animals. Sheep are one of 
the gold standard models used in neuroendocrinology due to the 
opportunity to perform serial blood (or cerebrospinal fluid) sam-
pling at short intervals (each 10 to 20 min) and over very long dur-
ations (more than 24 h) without affecting the basal physiology of 
the animal. Such advantages allow exploration of the intricacies 
of endocrine dynamics. In addition, very fine surgical approaches 
cannot be performed easily in rodents. For example, cannulation 
Figure 2. The multimodal potency of MRI. (A) T2 weighed MRI images of the sheep brain at four different dorso–ventral levels. (B) Resting-state networks de-
fined using resting state fMRI and associated analysis in anesthetized sheep. Three internal subnetworks involving the frontal region (red nodes), the occipito–
parietal region (orange nodes), and the diencephalic region (yellow nodes) can be defined. (C) Identification of some main fiber tracts (yellow) connecting the 
brainstem (right) to the frontal regions (left) and visualized by diffusion tensor imaging within the sheep brain.
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of the portal blood system in the pituitary, which allows sampling 
of gonadotropin-releasing hormone directly at the site of its re-
lease (Clarke and Cummins, 1982), is not possible in rodents.
Without being exhaustive, the previous section shows quite 
clearly that large animal models have specific advantages when 
considering their use as experimental models. These assets pro-
vide an exciting potential for their use in preclinical or transla-
tional research and explains why their use is currently gaining 
popularity. Sheep are now used to study various pathophysio-
logical conditions including (but not limited to) fetal growth 
during gestation (Harding and Bloomfield, 2004), epilepsy 
(Opdam et al., 2002), or stroke (Boltze et al., 2018).
MRI in large animal models presents clear advantages: 1) the 
methodology is not invasive; 2) MRI can be used for longitu-
dinal studies, enabling the long-term follow-up on the effect of 
experimental manipulations; 3) MRI is highly multimodal, al-
lowing acquisition of complimentary information (anatomical, 
functional, etc.) on the same animal within the same imaging 
session; 4) being noninvasive, MRI offers the possibility to use 
animals as their own controls, therefore limiting variability and 
increasing statistical power; and 5) it is possible to scan large 
animals (sheep, pigs, and goats) on current scanners, which are 
becoming more common in clinical and research environments.
For these reasons, the use of MRI in large animal models 
has been progressively increasing for fundamental or transla-
tional neuroscientific research (for example, Nuruddin et al., 
2013). The first reported preclinical study used fMRI, com-
bined with electroencephalography, for the localization of epi-
leptic foci in the sheep brain (Opdam et al., 2002). Technical 
approaches combining anatomical MR images and surgical 
stereotactic access to the brainstem (Staudacher et al., 2014) 
or microelectrocorticography grid implantation in the map-
ping of sensory cortex were then developed in the sheep brain 
(Gierthmuehlen et al., 2014). More recently, Lee et al. (2015) 
imaged sheep brains using both fMRI and DTI protocols. 
Imaging studies have also been conducted in pigs. For example, 
fMRI has been used to evaluate maturation of the brain in 
minipigs from the early postnatal period to 6 mo of age to ex-
plore whether the sequence of development of the visual cortex 
and its spatial localization is similar to that in primates (Fang et 
al., 2006). MRI has been also used to track the recovery of is-
chemia following transplantation of induced pluripotent stem 
cell-derived neural stem cells in a pig model (Baker et al., 2017).
Although these studies have shown that large animal models 
may be appropriate for brain in vivo structural and functional 
MR assessments, they are usually illustrative/qualitative, rely on 
limited numbers of subjects, and are without any systematic and 
quantitative group analyses—because the necessary tools to pro-
cess and analyze the images are lacking. In the field of neurosci-
ence, brain analysis requires the registration of each single subject 
image into a common reference space, also known as a template 
image, which is generally associated with an atlas of brain struc-
tures. These tools allow valid analysis of images and facilitate: 
1) statistical inferences over voxel intensities or shape variation 
of brain structures (e.g., voxel-based morphometry), 2) identi-
fication of brain structures activated during fMRI or positron 
emission tomography (PET), 3) functional connectivity analysis 
where brain structures can be used as regions of interest (ROI).
Such MRI tools were lacking but have become available re-
cently. An MRI-based brain template for sheep was published 
in 2015 (Nitzsche et al., 2015), but it was incomplete, lacking, 
for example, the cerebellum or the olfactory bulbs. At the same 
time, we published another 3D MRI brain template with asso-
ciated gray matter, white matter, and cerebrospinal fluid tissue 
probability maps (Ella and Keller, 2015; Ella et al., 2017). T1- 
and T2-weighted templates, as well as linear and nonlinear tis-
sues probability maps, were computed from complete adult 
sheep brains acquired with native isotropic voxel sizes and at 
a higher resolution (Figure 3A). We also defined a stereotaxic 
atlas, where each brain structure is registered with a coordinate 
system common to the derived templates and tissue probability 
maps (Figure 3B and C). Finally, both cortical and subcortical 
structures were annotated and labeled using an existing histo-
logical atlas. Importantly, these tools (brain atlas, template, and 
probability maps) have also been developed in domestic pigs 
(Sauleau et al., 2009; Saikali et al., 2010) and Göttingen minipigs 
(Watanabe et al., 2001).
Finally, it is worth mentioning that although most of the 
studies are still performed in a clinical environment, with 
strong constraints including the availability of equipment and 
sanitary precautions, dedicated MRI platforms are starting to 
emerge with high-quality holding facilities for small rumin-
ants (sheep and goats), pigs, and even cattle. Two examples 
are the platform of the French National Agricultural Institute 
(INRA) in Nouzilly, France, which has been functioning since 
2013, or the MRI platform which will open at the Roslin 
Institute/University of Edinburgh. These platforms provide 
access to other imaging techniques (e.g., CT scan), as well as 
Figure 3. Steps for the realization of a sheep brain template and atlas. (A) 
Acquisition of brain MR images and computation of a MR template of the 
sheep brain in T1-weighted contrast. (B) Segmentation of cortical areas over-
laid on the template images. (C) Three-dimensional view of the segmented 
telencephalon.
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other experimental approaches, including full scanning facil-
ities and the possibility to perform studies in biological con-
tainment level 2. Such facilities are likely to increase within the 
main agricultural and veterinary academic institutions in the 
future, thereby facilitating the ability to perform fundamental 
or preclinical studies on large animal models. They also allow 
for optimized care of animals, in regard to ethical consider-
ations, especially because the general public usually considers 
these domestic species as more sensitive than rodents. Indeed, 
the fact that all facilities (breeding and housing of animals, 
imaging, and surgical facilities) are physically colocated helps 
us to reduce animal stress associated with transport and add-
itional manipulations.
An Example of Preclinical Research Using 
Sheep as a Model of a Pediatric Disease, 
Batten Disease
Batten disease is a group of rare genetic lysosomal diseases 
also known as the neuronal ceroid lipofuscinoses (NCL; Mole 
et al., 2011). These neurodegenerative lysosomal storage dis-
eases predominantly affect children and are to date the most 
prevalent group of progressive childhood encephalopathies. 
Different forms of the disease are caused by mutations in 
various genes, with autosomal recessive mutations in CLN5 
and CLN6 genes causing late-infantile variants (Kousi et al., 
2012). The onset of late-infantile Batten disease usually occurs 
between 18 mo and 8 yr of age. Symptoms, which increase with 
age, include regression of motor and sensory functions, blind-
ness, ataxia, and dementia, leading to premature death around 
15 to 20 yr of age (Mole et al., 2011). Once diagnosed, the life 
expectancy of children is usually limited to a further 3 to 5 yr. 
To date, there is no curative treatment.
Understanding the pathophysiological mechanisms of 
Batten disease is still limited. The pathology is characterized 
by extensive brain atrophy, especially at the cortical level. In 
most forms, a clear accumulation of  storage bodies, predom-
inantly composed of  subunit c of  the mitochondrial ATP syn-
thase, can be observed in most cells but this accumulation is 
unlikely to be responsible for the pathological mechanisms 
(Palmer et al., 2013).
Various naturally occurring animal models of Batten dis-
ease exist, including sheep models (Palmer et al., 2011, 2013; 
Bond, et al., 2013). Two main forms have been identified: a 
CLN5 form observed in Borderdale sheep (Frugier et al., 2008) 
and a CLN6 form in Merino and South Hampshire sheep 
(Tammen et al., 2006). Both CLN5 (CLN5−/−) and CLN6 af-
fected (CLN6−/−) sheep share the main neuropathological 
features of the human disease, with progressive brain degener-
ation and a decline in motor and sensory function (blindness). 
Affected sheep decline to a humane endpoint before 20 to 24 
mo of age. Both forms of NCL in sheep therefore represent 
excellent models to explore key questions such as: 1) when the 
disease starts and the timeline for progression of the disease; 
2) why some brain regions are more affected than others; and 
most importantly 3) if  therapeutic strategies can be established 
to stop or at least slow down disease progression.
In this context, MRI offers advantages to understand the 
relationship between the symptoms and the pathological mech-
anisms. Indeed, MRI is noninvasive by nature and is a perfect 
approach to perform longitudinal studies to track disease pro-
gression as well as the continuing effectiveness of therapeutic 
approaches such as viral-mediated gene therapy. Such trials ex-
tend over several years and require long-term monitoring of 
animals without prematurely sacrificing them for postmortem 
neuropathological evaluation.
A first approach in affected sheep used CT scanning with 
associated 3D reconstruction of  the intracranial volume to 
track the brain neurodegeneration in CLN5−/− and CLN6−/− 
animals (Russell et al., 2018). Intracranial volume loss was 
minimal until 10 mo of  age. After this age, the intracranial 
volume of  both CLN5−/− and CLN6−/− animals reduced rap-
idly while unaffected animals maintained a stable intracranial 
volume. In addition, the intracranial volume changes re-
flected the previously established regionality of  the pathology 
(Oswald et al., 2008).
Although the CT scan is adapted to image “hard” tissues 
(skull bone), it provides limited information on gray matter–
white matter and other soft tissue delineation in the brain. 
In contrast, MRI allows exploration of soft tissues and can 
therefore be used to track the neurodegenerative process in 
more detail. In a preliminary study, Sawiak et al. (2015) fol-
lowed the degenerative process in CLN6−/− sheep during the 
terminal stages of disease (17–22 mo). They validated the use 
of longitudinal MRI to study the dynamics of progressive 
neurodegeneration and confirmed the pronounced cortical at-
rophy in affected sheep. Significant atrophy was also observ-
able in other brain regions such as the amygdala and the basal 
ganglia at the terminal stage of the disease. Importantly, the 
approach was sensitive enough to measure significant changes 
in the cortex over a 5-mo period, even after around 40% of the 
cortical volume was already lost at the beginning of the study.
Recently, Mitchell et al. (2018, Figure 4) aimed to charac-
terize disease progression in CLN5−/− Borderdale sheep, and 
most importantly, to track and monitor the long-term efficacy 
of CLN5 gene therapy. Two viral vector platforms were used: 
single-stranded adeno-associated viral serotype 9 (ssAAV9) or 
lentivirus. Both vectors prevented the stereotypical disease de-
velopment when administered by intracerebroventricular injec-
tion to presymptomatic lambs at 2 to 4 mo of age. The only 
clinical sign observed was delayed-onset visual loss, occurring 
between 20 and 24 mo. Despite this visual loss, the treated sheep 
were phenotypically normal at 27 mo of age, having normal 
social relationships. When tested in an open field, they showed 
no sign at all of the behavioral and neurological signs usually 
observed in the advanced stages of disease. One ssAAV9-treated 
animal has been retained until 62 mo old, which is 3 times older 
than the normal lifespan of untreated CLN5−/− sheep. Because 
gene therapy is more likely to begin after clinical diagnosis is 
established, a self-complementary AAV9-CLN5 was injected 
into 7-mo-old CLN5−/− sheep in a second trial (Mitchell et al., 
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2018). Consistent with the first trial, this treatment stopped 
progression of the disease, allowed maintenance of cognitive 
abilities, and the survival of these animals much exceeded their 
natural lifespan.
Longitudinal CT and MRI were used to track and monitor 
the brain volume and architecture. Although untreated CLN5−/− 
sheep showed a massive shrinkage of the brain (Mitchell et al., 
2018), treated CLN5−/− sheep showed no sign of cerebral at-
rophy, with preservation of brain structures and volumes. MRI 
of sheep treated before development of clinical signs confirmed 
that CLN5 gene therapy afforded complete protection against 
the profound cortical atrophy, stereotypical ventricular en-
largement, and cranial thickening.
Postmortem histological analysis demonstrated wide-
spread expression of the CLN5 protein in the brain and spinal 
cord in all treated sheep, regardless of the vector used. CLN5 
immunoreactivity was especially evident in the cerebral cortex 
and hippocampus of treated sheep, and transduced cells were 
morphologically neuronal-like. In contrast, there was no CLN5 
protein expression in the untreated CLN5−/− sheep brain. As a 
whole, these data demonstrate the efficacy of CLN5 gene therapy, 
using three different viral vectors, and provide a strong rationale 
for clinical translation to CLN5-affected human patients. They 
also highlight the validity of MRI approaches and the use of the 
sheep models of Batten disease for preclinical studies.
Conclusion
The principles and advantages of the use of MRI in large 
animal models for preclinical purposes are highlighted in this 
review. Large animals present characteristics that make them 
more relevant than many other smaller animals for a range of 
applications, thus increasing the predictive values of the results 
obtained. Development of useful large animal models, ad-
vanced MRI to assess the brain in vivo, and newly developed 
analytical tools provide an incredibly powerful multimodal, 
noninvasive, and ethical framework with which to investigate a 
range of questions of importance to fundamental, agricultural, 
and preclinical research.
Interestingly, the increased access and use of MRI in large 
animal models highlight paradoxically our lack of fundamental 
physiological knowledge of these species. If  we take the brain 
as an example, it is clear that deep brain structures have been 
relatively well described. However, many other regions (cortical 
regions) remained poorly explored at both the functional and 
anatomical levels. For example, there is still no functional map 
for domestic animals that is equivalent to the Brodmann’s area 
descriptions in human and nonhuman primates. As a result, lo-
calization and interpretation of activations identified by func-
tional imaging remain somewhat imprecise. This limitation is 
also an opportunity: the development of imaging studies on 
large animal models represents a unique chance to provide new 
and original knowledge regarding the physiology of these ani-
mals, which can be used for the development of new applica-
tions in the field of animal science.
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